Overexpression of cyclins a and B as markers of neoplastic glandular lesions of the cervix

Gynecologic Oncology

Volumn 92, Issue 2, 2004, Pages 628-634

  El Ghobashy, Alaa A ^a   Shaaban, Abeer M ^a   Herod, Jonathan ^b   Innes, Jenny ^a   Prime, Wendy ^a   Herrington, C Simon ^a,c  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Cervix; Cyclins; Glandular lesions

Indexed keywords

ANTIGEN; CYCLIN A; CYCLIN B; CYCLIN D; CYCLIN E; MONOCLONAL ANTIBODY; PARAFFIN; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ANALYTIC METHOD; CANCER INVASION; CONFERENCE PAPER; CONTROLLED STUDY; ENDOMETRIAL DISEASE; ENDOMETRIOSIS; FEMALE; GENE OVEREXPRESSION; HEAT; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METAPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX TUMOR;

EID: 0842332126     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.11.010     Document Type: Conference Paper

References (36)

1. Stockton D., Cooper P., Lonsdale R.N. Changing incidence of invasive adenocarcinoma of the uterine cervix in East Anglia. J. Med. Screen. 4(1):1997;40-43.
2. Vizcaino A.P., Moreno V., Bosch F.X., Munoz N., Barros-Dios X.M., Parkin D.M. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int. J. Cancer. 75(4):1998;536-545.
3. Jaworski R.C. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix. Semin. Diagn. Pathol. 7(3):1990;190-204.
4. Azodi M., Chambers S.K., Rutherford T.J., Kohorn E.I., Schwartz P.E., Chambers J.T. Adenocarcinoma in situ of the cervix: management and outcome. Gynecol. Oncol. 73(3):1999;348-353.
5. Duska L.R., Flynn C.F., Chen A., Whall-Strojwas D., Goodman A. Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology. Obstet. Gynecol. 91(2):1998;278-282.
6. Khleif S.N., DeGregori J., Yee C.L., Otterson G.A., Kaye F.J., Nevins J.R.et al. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc. Natl. Acad. Sci. U. S. A. 93(9):1996;4350-4354.
7. Serrano M., Hannon G.J., Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 366(6456):1993;704-707.
8. Rosenthal E.T., Hunt T., Ruderman J.V. Selective translation of mRNA controls the pattern of protein synthesis during early development of the surf clam, Spisula solidissima. Cell. 20(2):1980;487-494.
9. Johnson D.G., Walker C.L. Cyclins and cell cycle checkpoints. Annu. Rev. Pharmacol. Toxicol. 39:1999;295-312.
10. Kamb A., Gruis N.A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S.V.et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 264(5157):1994;436-440.
11. Nobori T., Miura K., Wu D.J., Lois A., Takabayashi K., Carson D.A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 368(6473):1994;753-756.
12. Bartkova J., Lukas J., Muller H., Lutzhoft D., Strauss M., Bartek J. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer. 57(3):1994;353-361.
13. Chao Y., Shih Y.L., Chiu J.H., Chau G.Y., Lui W.Y., Yang W.K.et al. Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Res. 58(5):1998;985-990.
14. Dutta A., Chandra R., Leiter L.M., Lester S. Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer. Proc. Natl. Acad. Sci. U. S. A. 92(12):1995;5386-5390.
15. Gillett C., Fantl V., Smith R., Fisher C., Bartek J., Dickson C.et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 54(7):1994;1812-1817.
16. Hall M., Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res. 68:1996;67-108.
17. Keyomarsi K., Pardee A.B. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 90(3):1993;1112-1116.
18. Musgrove E.A., Hamilton J.A., Lee C.S., Sweeney K.J., Watts C.K., Sutherland R.L. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol. Cell. Biol. 13(6):1993;3577-3587.
19. Wang J., Chenivesse X., Henglein B., Brechot C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature. 343(6258):1990;555-557.
20. Wang J., Zindy F., Chenivesse X., Lamas E., Henglein B., Brechot C. Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma. Oncogene. 7(8):1992;1653-1656.
21. Buckley M.F., Sweeney K.J., Hamilton J.A., Sini R.L., Manning D.L., Nicholson R.I.et al. Expression and amplification of cyclin genes in human breast cancer. Oncogene. 8:1993;2127-2133.
22. Southern S.A., Herrington C.S. Differential cell cycle regulation by low- and high-risk human papillomaviruses in low-grade squamous intraepithelial lesions of the cervix. Cancer Res. 58(14):1998;2941-2945.
23. Paterlini P., Suberville A.M., Zindy F., Melle J., Sonnier M., Marie J.P.et al. Cyclin A expression in human hematological malignancies: a new marker of cell proliferation. Cancer Res. 53(2):1993;235-238.
24. Furihata M., Ishikawa T., Inoue A., Yoshikawa C., Sonobe H., Ohtsuki Y. et al. Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma. Clin. Cancer Res. 2(10):1996;1781-1785.
25. Dobashi Y., Shoji M., Jiang S.X., Kobayashi M., Kawakubo Y., Kameya T. Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas. Am. J. Pathol. 153(3):1998;963-972.
26. Aaltomaa S., Lipponen P., Eskelinen M., Ala-Opas M., Kosma V.M. Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer. Prostate. 39(1):1999;8-15.
27. Furihata M., Ohtsuki Y., Sonobe H., Shuin T., Yamamoto A., Terao N.et al. Cyclin A overexpression in carcinoma of the renal pelvis and ureter including dysplasia: immunohistochemical findings in relation to prognosis. Clin. Cancer Res. 3(8):1997;1399-1404.
28. Wang A., Yoshimi N., Suzui M., Yamauchi A., Tarao M., Mori H. Different expression patterns of cyclins A, D1 and E in human colorectal cancer. J. Cancer Res. Clin. Oncol. 122(2):1996;122-126.
29. Kyushima N., Watanabe J., Hata H., Jobo T., Kameya T., Kuramoto H. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables. J. Cancer Res. Clin. Oncol. 128(6):2002;307-312.
30. King R.W., Jackson P.K., Kirschner M.W. Mitosis in transition. Cell. 79(4):1994;563-571.
31. Southern S.A., McDicken I.W., Herrington C.S. Evidence for keratinocyte immortalization in high-grade squamous intraepithelial lesions of the cervix infected with high-risk human papillomaviruses. Lab. Invest. 80(4):2000;539-544.
32. Kanai M., Shiozawa T., Xin L., Nikaido T., Fujii S. Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin-dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix. Cancer. 82(9):1998;1709-1719.
33. Innocente S.A., Abrahamson J.L., Cogswell J.P., Lee J.M. p53 regulates a G2 checkpoint through cyclin B1. Proc. Natl. Acad. Sci. U. S. A. 96(5):1999;2147-2152.
34. Bodrug S.E., Warner B.J., Bath M.L., Lindeman G.J., Harris A.W., Adams J.M. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J. 13(9):1994;2124-2130.
35. Lovec H., Grzeschiczek A., Kowalski M.B., Moroy T. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J. 13(15):1994;3487-3495.
36. Wang T.C., Cardiff R.D., Zukerberg L., Lees E., Arnold A., Schmidt E.V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 369(6482):1994;669-671.